A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma (Pfizer PD)

Share this content:
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma (Pfizer PD)
 
Sponsors and Collaborators
University of California, San Francisco
Pfizer
 
Contact
Angelina Nicole, MFA
 
Valerie Kivett, BS
415-353-2076
 
Principal Investigators
Michael D Prados, MD
University of California, San Francisco
 
ClinicalTrials.gov Identifier
NCT01227434

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs